Berberine can improve blood sugar control. Learn the role of berberine in lowering blood sugar levels and how long it takes for it to produce such a beneficial effect.

Berberine, dubbed 'nature's Ozempic,' is gaining traction as a natural weight loss alternative. Research indicates it modestly aids weight loss and improves metabolic health, particularly for those ...

Q. I have had several physicians trying to get me back on statins. There is no family history of heart disease.

After analyzing ingredients, benefits, and customer feedback, Lipovive stands out as a promising fat-burning supplement for ...

India has launched an anti-dumping investigation on imports of tuberculosis drug Ethambutol Hydrochloride from China and Thailand. Based on an application filed by drugmaker Lupin, the probe by the ...

People searching for an affordable way to lose weight with a GLP-1 drug may come across products marketed as “GLP-1 patches” online. They’re advertised as helping to reduce cravings, control appetite ...

At the product level, HCL is making sure its software can run in different ways, depending on what customers prefer. As data sovereignty and regulatory demands sharpen across markets, HCLSoftware, ...

https://www.thehindubusinessline.com/markets/focus-will-be-on-swiggy-infosys-hcl-tech-apollo-hospital-iex-akzo-nobel-ceinsys-tech-torrent-power-indian-hotels ...

NEEDHAM, Mass., Sept. 19, 2025 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a commercial-stage biotechnology company focused on the discovery, development and ...

IT stocks such as Infosys Ltd, Tata Consultancy Services (TCS), Wipro, HCL Technologies and Tech Mahindra may see selling pressure today, September 22, after the White House announced a revised H-1B ...

The market capitalisation of information technology (IT) stocks has taken a sharp hit after US President Donald Trump stunned the tech world by announcing up to a 50-fold increase in the cost of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...